🇯🇵 Xofluza in Japan

Xofluza (BALOXAVIR MARBOXIL) regulatory status in Japan.

Marketing authorisations

PMDA

  • Application: Xofluza Initial Approval
  • Local brand name: Xofluza Initial Approval
  • Status: approved

Read official source →

PMDA

  • Application: Xofluza Partial Change Approval
  • Local brand name: Xofluza Partial Change Approval
  • Status: approved

Read official source →

Xofluza in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in Japan

Frequently asked questions

Is Xofluza approved in Japan?

Yes. PMDA has authorised it; PMDA has authorised it.

Who is the marketing authorisation holder for Xofluza in Japan?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.